UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000006078
Receipt number R000007192
Scientific Title A phase II study of Erlotinib as 2nd-line treatment for patients with StageIIIB/IV non-small cell lung cancer
Date of disclosure of the study information 2011/07/30
Last modified on 2018/02/19 15:12:50

No. Disposal Last modified on Item of update
1 Insert 2011/07/29 22:03:36
2 Update 2018/02/19 15:12:50 Recruitment status